Schedule 13G ownership disclosure

VITAE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 92847N103

Event date: 2015-09-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-15-002173
Form type
SC 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Sep 30, 2015
Reporting period
Sep 28, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub